Skip to main content
Equibles

Ramtin Agah

RenovoRx, Inc. (RNXT)

Chairman

RenovoRx, Inc. (RNXT)

Equibles does not estimate personal net worth.

Get an email with a short summary when RenovoRx, Inc. publishes a filing, an earnings call transcript or a press release.

Get RNXT alerts

About Ramtin Agah

Ramtin Agah is recorded as Chairman at RenovoRx, Inc. (RNXT). The newest filing on record that lists Ramtin Agah as Chairman at RenovoRx, Inc. (RNXT) is dated April 30, 2026. The proxy statement of RenovoRx, Inc. reports total compensation of $692,246 for Ramtin Agah in fiscal 2025. Disclosed compensation is on record for 4 fiscal years. Ramtin Agah has spoken on 3 earnings calls across 1 company, most recently for RenovoRx, Inc. on August 12, 2026. RenovoRx, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at RenovoRx, Inc. includes Shaun Bagai (CEO and Board Member), Shaun R. Bagai (CEO and Board Member), Ramtin Agah, M.D. (Chairman) and 7 others.

Ramtin Agah on recent calls

“Before discussing the broader opportunity, let me briefly remind everyone of the science at the core of what we're building.”
Chairman, Second Quarter 2026 Financial Results Conference Call ·
“This quarter marks another important step forward in RenovoRx's fourteen-year journey transforming a bold concept into a new therapeutic option that is now reaching patients across the country.”
Chairman, RenovoRx, Inc. Q3 FY2025 Earnings Call ·
“2025 thus far has marked the most transformational period in our company's history. As everyone knows, late last year, we launched the commercialization of the RenovoCath device as a standalone product within its FDA-cleared indications for use.”
Chairman, RenovoRx, Inc. Q2 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at RenovoRx, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 RenovoRx, Inc. (RNXT) — $692,246
2024 RenovoRx, Inc. (RNXT) — $603,019
2023 RenovoRx, Inc. (RNXT) — $506,772
2022 RenovoRx, Inc. (RNXT) — $434,655

Recent activity